library_booksGuides Library

All GLP-1 Journey Guides

115 hand-edited guides organized by topic, category, and medication. New guides go live every day.

Filter by medication

rocket_launchPipeline & future · 4 guides

Drugs in development — Retatrutide, CagriSema, oral vs injectable, monthly.

CagriSema pairs cagrilintide (an amylin analog) with semaglutide in one weekly injection. Here's the trial data so far and what to expect.

Could a once-monthly GLP-1 replace weekly pens? Here's what's in development, what the science allows, and what to expect in the next few years.

Pill or pen? Oral GLP-1s like Rybelsus and injectables like Wegovy work differently. Here's how to think about efficacy, timing, and fit.

Retatrutide is Eli Lilly's GIP/GLP-1/glucagon triple agonist in Phase 3. Here's the trial data so far and what FDA approval could look like.